Leif Niclas Fredrik Löwgren
Direttore/Membro del Consiglio presso Omnivation AB
Posizioni attive di Leif Niclas Fredrik Löwgren
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Omnivation AB | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Leif Niclas Fredrik Löwgren
Precedenti posizioni note di Leif Niclas Fredrik Löwgren
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GRUVAKTIEBOLAGET VISCARIA | Direttore/Membro del Consiglio | - | 14/05/2019 |
| NEXTCELL PHARMA AB | Direttore/Membro del Consiglio | 01/01/2017 | - |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Direttore/Membro del Consiglio | 01/01/2017 | - |
QuiaPEG Pharmaceuticals AB
 QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Direttore/Membro del Consiglio | - | - |
Formazione di Leif Niclas Fredrik Löwgren
| University of Stockholm | Masters Business Admin |
Statistiche
Distribuzione geografica
| Svezia | 7 |
Posizioni
| Director/Board Member | 5 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 4 |
| Non-Energy Minerals | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GRUVAKTIEBOLAGET VISCARIA | Non-Energy Minerals |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
| NEXTCELL PHARMA AB | Health Technology |
| Aziende private | 2 |
|---|---|
QuiaPEG Pharmaceuticals AB
QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Health Technology |
| Omnivation AB |
